| abstract |
The present invention relates to 4- (2-fluorophenyl) -6-methyl-2- (piperazin-1-yl) thieno [2,3-d] pyrimidine hydrochloride crystal form It relates to a novel crystalline form of -6-methyl-2- (piperazin-1-yl) thieno [2,3-d] pyrimidine salt. The invention also relates to compositions comprising such crystalline forms as well as methods of making such crystalline forms and methods of using such crystalline forms, for example, in the treatment of gastrointestinal and / or genitourinary disorders. |